Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer
Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds
Avastin Improves PFS Compared To Chemo Alone
Two Second-Line CML Drugs Work Front-Line, Studies Find
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget
- NIH calls for comment on proposal to limit the number of RPGs per PI
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe









